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Phosphatidylinositol transfer proteins (PITPs) regu-
late the interface between lipid metabolism and cellular
functions. We now report that ablation of PITP func-
tion leads to aponecrotic spinocerebellar disease, hypo-
glycemia, and intestinal and hepatic steatosis in mice.
The data indicate that hypoglycemia is in part associ-
ated with reduced proglucagon gene expression and gly-
cogenolysis that result from pancreatic islet cell defects.
The intestinal and hepatic steatosis results from the
intracellular accumulation of neutral lipid and free
fatty acid mass in these organs and suggests defective
trafficking of triglycerides and diacylglycerols from the
endoplasmic reticulum. We propose that deranged intes-
tinal and hepatic lipid metabolism and defective proglu-
cagon gene expression contribute to hypoglycemia in
PITP/ mice, and that hypoglycemia is a significant
contributing factor in the onset of spinocerebellar dis-
ease. Taken together, the data suggest an unanticipated
role for PITP in with glucose homeostasis and in mam-
malian endoplasmic reticulum functions that interface
with transport of specific luminal lipid cargoes.
PITPs1 mobilize PtdIns or PtdCho between membrane bilay-
ers in vitro (1, 2). In vivo studies demonstrate that PITPs
control the interface between membrane trafficking and lipid
metabolic pathways in yeast (3–6). By contrast, the physiolog-
ical functions for mammalian PITPs, which are structurally
unrelated to yeast PITPs (7, 8), are not understood at either the
cellular or organismal levels.
Mammals express at least three soluble PITPs: PITP,
PITP, and rdgB (9–11). PITP and PITP share 77% pri-
mary sequence identity, are encoded by distinct genes, and
exhibit biochemical differences. Yet both PITP and PITP
(and even yeast PITPs) function as soluble factors that stimulate
various reconstitutions of PIP-dependent functions in permeabi-
lized mammalian cells. These functions include regulated and
constitutive membrane trafficking and phospholipase C-
dependent signaling through G-protein-coupled receptors (12–
14). Given the lack of PITP specificity in these assays, it re-
mains unclear how faithful such reconstitutions are in
reporting physiological functions for mammalian PITPs.
Genetic studies are providing initial clues regarding PITP
function in metazoans. An inherited form of light-enhanced
retinal degeneration in Drosophila results from inactivation of
a membrane-bound PITP (15). In mice, reduction of PITP to
18% of wild-type levels is the basis for the vibrator neurode-
generative disorder (16, 26). Gene ablation approaches suggest
PITP plays an essential housekeeping function, whereas
PITP is nonessential for ES cell viability and is not a quanti-
tatively significant factor in membrane trafficking, PIP metab-
olism, or growth factor signaling in ES cells (17).
In this report, we describe the consequences associated with
ablation of PITP function in the mouse. We find that PITP,
although dispensable for prenatal development, is required for
neonatal survival. PITP/ neonates suffer from a severe
spinocerebellar neurodegenerative disease and exhibit defects
in dietary fat and -tocopherol transport across the small in-
testine. This intestinal steatosis in some respects resembles
CRD, a human disorder of unknown molecular etiology (18, 19).
Liver steatosis is also prominent in the mutant mice, suggest-
ing the possibility that PITP nullizygosity also compromises
lipoprotein assembly and/or neutral lipid secretion in hepato-
cytes. Finally, PITP/ mice are severely hypoglycemic. Our
results suggest a novel and unanticipated role for PITP in
regulating cargo-specific lipid transport from the enterocyte
and hepatocyte ER, endocrine pancreas function, and glycogen
metabolism.
EXPERIMENTAL PROCEDURES
Generation and Genotyping of PITP/ Mice—AB1-derived
/PITP1::neo* ES cells have been described previously (17). The
/PITP::neo/puro ES cells corresponded to the OST 1152 line (Lexicon
Genetics OmniBankTM library (20)). Mice were generated by injection of
ES cells into C57BL/6 blastocysts, implantation of blastocysts into
pseudopregnant foster mothers, and identification of male chimeric
mice competent for germ line transmission of each allele. Genotypes for
PITP1::neo* mice (JG line) were determined by using a three-primer
PCR assay. We employed a primer specific for the homozygous
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PITP/ genotype (AB-2; 5-GCGAGGCATCACTCTTCCCCTC-3),
the heterozygous PITP/ genotype (AB-1B; 5-CACCATCCCCCAC-
GGTGACTG-3), and the PITP/ genotype (PG-1; 5-GAATGTGTG-
CGAGGCCAGAGG-3) in a 33-cycle reaction (53 °C annealing temper-
ature). Genotypes for PITP::neo/puro mice (L1 line) were determined
in two steps. First, a two primer assay that monitored Neo distinguishes
PITP/ from PITP/ and PITP/ mice. Primers GE-UP (5-
GGGCGCCCGGTTCTTT TTGTGA-3) and GE-DO (5-TTGGTGGTC-
GAATGGGCAGGTAGC-3) were used in a 28-cycle reaction (60 °C an-
nealing temperature). To distinguish PITP/ from PITP/ L1
mice, we resorted to immunoblot analyses of mouse brain using PITP-
specific serum (17).
Serum Analyses—Blood was collected from mice immediately after
heart puncture and clotted, and serum was clarified by centrifugation.
Serum glucose was determined by using either the Trinder assay (Sig-
ma) or was measured by Antech Diagnostics (Farmingdale, NY). Insu-
lin and -hydroxybutyrate were determined using the Immunoassay
System (Crystal Chem Inc.) and the -hydroxybutyrate assay kit (Sig-
ma), respectively. All other serum analyses were performed by Antech
Diagnostics (Farmingdale, NY).
Carcass Analyses—Carcass analyses were as described previously
(21). Gastrointestinal tracts were removed (stomach, small and large
intestine, and cecum) and carcasses weighed. Body water content of
eviscerated carcasses was determined by drying to constant weight in a
60 °C oven and measuring differences between the pre- and post-drying
carcass mass. Dried carcasses were minced, ground to a homogeneous
mixture, and extracted with petroleum ether in a Soxhlet apparatus to
determine fat mass and fat-free dry mass. Fat-free dry mass was
burned overnight at 600 °C (8 h) to determine eviscerated carcass ash.
Histological Analysis—Mice were anesthetized with 1.25% Avertin
and perfused with phosphate-buffered saline, 4% paraformaldehyde.
Duodenum, ileum, cerebellum, pancreas, and spinal cord were har-
vested, flushed with fixative (duodenum and ileum only), dissected, and
infused with fixative for 24 h. Samples were mounted in paraffin, and
5-m-thick sections were stained and mounted. These sections were
rehydrated by serial transfer from xylene to 50% EtOH, stained with
hematoxylin/eosin, and mounted in Permount (Fisher). Where osmium
staining was employed, duodenal and liver sections were stained in 5%
potassium dichromate, 2% osmium tetroxide for 8 h prior to paraffin
embedding (22) and counterstained with toluidine blue O.
Whole brains were extracted from mice perfused with 4% paraform-
aldehyde and 2.5% glutaraldehyde, washed for several days in phos-
phate-buffered saline, and mounted in paraffin. Brains were sliced in
half along the sagittal plane; each half was embedded in paraffin; and
5- or 8-m-thick slices were mounted onto treated slides. Sections were
rehydrated to 50% EtOH. For visualization of Purkinje cells, slices were
incubated with goat anti-calbindin antibodies (Santa Cruz Biotechnol-
ogy; Santa Cruz, CA) and developed with the Vectastain ABC kit
(Vector Laboratories, Burlingame, CA). After incubation in 2% osmium
fumes for 10 min, slices were counterstained with toluidine blue O.
For Oil Red O staining, livers were extracted from mice perfused
with 4% paraformaldehyde, washed with phosphate-buffered saline,
and frozen at 20 °C. Frozen livers were mounted, sectioned (8 M),
fixed to a histological slide, and placed in absolute propylene glycol (2
min). Slides were moved into Oil Red O solution (Newcomer Supply,
Middleton, WI, catalog number 12722) for 1 h, differentiated in 85%
propylene glycol (1 min), rinsed 2 in distilled water, counterstained
with hematoxylin (10 s), and mounted in glycerin.
Electron Microscopy—Mice were perfused with 4% formaldehyde,
2.5% glutaraldehyde. Biopsies from intestine, liver, and spinal cord
were post-fixed with 1% OsO4, dehydrated with acetone, embedded in
epoxy (23), sectioned (65 nm-thick), and stained with 4% uranyl acetate
and Sato’s lead mixture (24). Samples were viewed at 80 kV in a Phillips
Tecnai 12 microscope (FEI Co., Eindhoven, The Netherlands) and im-
aged with a Gatan MultiScan model 794 digital camera (Gatan, Pleas-
anton, CA).
Epoxy-embedded samples were sectioned for histological analysis
(2-m thickness) and stained with 1% toluidine blue O in 1% sodium
borate. Digital images were collected with a SPOT RT digital camera
(Diagnostic Instruments, Inc., Sterling Heights, MI), using Plan Fluor
Nikon objectives mounted in a Nikon Eclipse E400 microscope (Nikon
Inc., Melville, NY). Morphometric analysis of spinal cord sections was
carried out with Scion Image software (Scion Corp., Frederick, MD).
-Tocopherol Analyses—Brain -tocopherol was extracted as de-
scribed (25), injected onto a 250  4.6 mm Phenomenex ODS 20 re-
versed phase C18 column (5-m particle diameter), and eluted with
methanolic 0.05% ammonium acetate using a flow rate of 1.5 ml/min.
The high pressure liquid chromatography system consisted of a
PerkinElmer Life Sciences model LC200 gradient pump, an AS 200
Autosampler, and an LC 295 programmable UV-visible light detector
set at 292 nm.
Liver Glycogen Analysis—Quantification of liver glycogen was by the
method of Passonneau and Lauderdale (26). Glycogen was extracted
from acidified liver homogenates and hydrolyzed to glucose with amylo-
glucosidase (Sigma). Glucose was determined by a glucose oxidase-
coupled Trinder assay (Sigma).
Adenylate Nucleotide Analysis—ATP and ATP/ADP ratios were
measured using the ApoGlowTM kit (BioWhittaker Molecular Applica-
tions; Rockville, MD). Samples (0.5 mg tissue) were collected and rap-
idly frozen. Tissues were thawed and homogenized in the presence of a
nucleotide-releasing mixture supplied by the manufacturer. Acid-ex-
tracted ATP was assayed with a luciferase-based system with picomolar
sensitivity. ADP was converted to ATP and measured after a 5-min
incubation at 22 °C.
Pancreatic Histology—Whole pancreas from mice perfused with 4%
paraformaldehyde was embedded in paraffin and serially sectioned
(thickness  5 m). Islet numbers were assessed by sequential obser-
vation of hematoxylin/eosin-stained sections. Care was exercised to
separate islets from patches of connecting ducts and intervening con-
nective tissue, and not to re-score the same islet in successive sections.
Islet-like, encapsulated structures larger than 100 m that were de-
tected in at least three consecutive sections were scored as islets. The
total pancreatic area studied was similar in all sections.
RESULTS
PITP/ Mice Develop to Term—Ablation of PITP func-
tion in the mouse was achieved using two independent null
alleles. First, a homologous recombination vector was con-
structed where exons 8–10 of the PITP gene are replaced with
a neo cassette (Fig. 1A). This mutation (PITP::neo*) deletes
PITP residues 162–257, a region critical for PITP function
(17). Second, survey of the Lexicon Genetics OmniBankTM gene
trap library (see “Experimental Procedures”) identified an inser-
tion mutation in the PITP structural gene (PITP::neo/puro).
This allele is genetically similar (although not identical) to
PITP::neo* as it also truncates PITP after residue 162 (Fig.
1B). Mice were derived from each targeted ES cell line.
PITP/ offspring are phenotypically normal and fertile, and
mice homozygous for either of these two mutations exhi-
bit indistinguishable phenotypes. The phenotypic data pre-
sented below were obtained from both PITP1::neo* and
PITP::neo/puro homozygous animals.
Intercrosses with heterozygous mice carrying either
PITP1::neo* or the PITP::neo/puro allele yielded genotypes
consistent with a fully penetrant autosomal recessive muta-
tion. From a dedicated pool of 408 live births, 89 PITP/
progeny were recovered (Fig. 1C). The genotypic distribution of
106 PITP/, 213 PITP/, 89 PITP/ corresponds to a
1.000:2.009:0.840 ratio that approximates closely the 1:2:1 ra-
tio predicted by Mendel’s rules. Correct gene targeting in the
progeny was verified by PCR genotyping and immunoblotting
of brain extracts with a specific PITP antiserum (Fig. 1D).
Antibodies directed against the PITP N terminus failed to
detect a truncation product in mice homozygous for
PITP1::neo* or PITP::neo/puro, suggesting that both al-
leles represent null mutations. Finally, we find that relative
PITP levels are unchanged in PITP/ and PITP/ brain
(Fig. 1D), indicating that PITP/ mice do not activate com-
pensatory processes that increase PITP expression.
Neonatal Mortality of PITP/ Mice—PITP/ mice
failed to thrive and died at a very young age. In a sample pool
of 57 PITP/ mice, 40% died within 48 h after birth (Fig.
2A). These early P0 and P1 deaths were not characterized by
obvious external abnormalities. Moreover, postmortem analy-
ses revealed that the stomachs of the expired PITP/ mice
contained copious quantities of milk, indicating that mutant
animals had nursed. Of the PITP/ progeny that survived
past P1, a steady incidence of mortality was observed between
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FIG. 1. Generation and characterization of PITP-deficient mice. A, targeted replacement of the wild-type PITP locus with
PITP::neo*. Organization of the targeting vector is shown. Probe 1 represents a 500-bp DNA fragment that resides outside the bounds of the
targeting vector and is employed for diagnosis of targeting events. Exons 7–10 of the PITP structural gene are indicated as closed bars and are
numbered accordingly. Restriction enzyme sites: E, EcoRI; X, XbaI; K, KpnI; S, SacI. B, OmniBankTM gene trap library at the PITP locus.
Retroviral construct VICTR20 is depicted (20). The PITP::neo/puro mutation represents integration of VICTR20 between PITP exons 7 and 8
and truncates PITP after residue 162. The abbreviations used are as follows: LTR, long terminal repeat; PGK, phosphoglycerate kinase-1
promoter; puro, puromycin N-acetyltransferase gene; SD, spice donor sequence; SA, splice acceptor sequence; IRES, internal ribosome entry site;
geo, galactosidase/neomycin phosphotransferase fusion gene; pA, polyadenylation sequence. C, distribution of PITP genotypes in the F1. The
number of live births obtained for each PITP genotype (indicated at top), from a dedicated set of 408 F1 progeny of PITP/ intercrosses, is given
above the corresponding bar. D, confirmation of viable PITP/ progeny. Upper left panel, diagnostic PCR profiles of PITP/, PITP/, and
PITP/ progeny derived from a PITP/ intercross. Upper right panel, total brain lysates (20 g) harvested from each of five sibling pups
(genotypes indicated) derived from a PITP/ intercross were resolved by SDS-PAGE and developed by immunoblotting with PITP-specific
antibodies. Lower panel, immunoblot of PITP in brain lysates (20 g) from neonates of indicated genotype.
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FIG. 2. Overt phenotypes of PITP/ mice. A, mortality profile derived from a pool of 57 PITP/ mice generated from 5 mating pairs over
a period of 5 mating cycles. Data are presented as percentage of surviving progeny (/, open circles; /, closed circles) as a function of time
(postnatal day). B, rates of body mass increase of PITP/ and PITP/ littermates. Values represent averages for two sibling mice of each
genotype (/, open circles; /, closed circles). The data are representative. C, visual comparison of PITP/ and PITP/ littermates.
Genotypes are at bottom. D, stomachs (S) of age-matched PITP/ and PITP/ mice (P7) are filled with milk. Subcutaneous axillary (AF) and
inguinal (IF) fat pads are indicated. E, comprehensive chemical analysis of eviscerated carcasses. Measurements represent the averages from six
P6 and three P8 PITP/ animals (solid bars) and six P6 and three P8 PITP/ mice (hatched bars). The abbreviations used are as follows: total,
eviscerated carcass mass; FFDM, fat-free dry mass; and ASH, non-combustible carcass bone ash.
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P2 and P11. Almost all mice expired by P11, and only one
PITP/ mouse lived to P14 (Fig. 2A).
PITP/ progeny that survived past P1 were initially in-
distinguishable from PITP/ and PITP/ littermates in
size, external morphology, and behavior. By P4, however, two
phenotypes rapidly asserted themselves. First, most PITP/
mice were moribund and exhibited little spontaneous move-
ment. These mice did respond to touch, however. By contrast,
10% of the PITP/ mice experienced spontaneous seizures.
All PITP/ mice were severely ataxic and were generally
incapable of maintaining themselves upright. We also observed
coarse action tremors upon limb extension in PITP/ mice.
Second, these mutant mice failed to thrive. Although the
PITP/ mice gained body mass, they did so slowly (Fig. 2B).
By P10, surviving PITP/ mice were 2.5-fold less massive
than their PITP/ and PITP/ littermates (Fig. 2C).
PITP/ Mice Suckle Effectively—Several lines of evidence
indicate that the failure of PITP/ mice to thrive is not the
simple consequence of neurological defects. We observed
PITP/ mice in the act of suckling, and postmortem analy-
ses indicated both copious quantities of milk in stomachs of
these mice (Fig. 2D) and substantial amounts of digested mat-
ter throughout the PITP/ intestinal tract (not shown). The
suckling competence of PITP/ mice notwithstanding, the
mutant animals exhibited pathologically low body fat levels.
This reduction is obvious when the subcutaneous fat pads of
PITP/ and PITP/ mice are compared. Whereas
PITP/ controls exhibit large axillary and inguinal fat pads,
these structures are absent from PITP/ animals (Fig. 2D).
Chemical analyses of eviscerated carcasses quantified these
differences; PITP/ and PITP/ mice exhibited total body
fat contents of 15.0 	 1.1 and 4.0 	 0.5% of total body mass,
respectively (Fig. 2E). Significantly, the relative water contents
of PITP/ and PITP/ carcasses are similar (Fig. 2E),
indicating that PITP/ mice are not dehydrated, as would be
expected if there were substantial suckling defects. The rela-
tive fat-free dry mass contents and carcass bone ash contents
are also comparable (Fig. 2E). Consistent with those measure-
ments, we find that organ/total body mass ratios in PITP/
mice for brain, liver, and other major organs are also propor-
tional to total body mass (not shown).
Elevated Apoptosis and Purkinje Cell Defects in PITP/
Cerebellum—Nissl staining does not reveal obvious defects in
development or morphology of PITP/ cerebrum, thalamus,
hippocampus, or cerebellum. Normal cellularity was observed
in all regions examined (data not shown). However, PITP
insufficiencies evoked functional defects in the cerebellum.
These defects were apparent at several levels. Whereas
TUNEL staining showed a sparse and random distribution of
apoptotic foci in wild-type brain, apoptosis was more prevalent
throughout PITP/ cerebellum. This is particularly evident
in the external granule layer of mutant cerebellum (Fig. 3A).
Second, we find Purkinje cell defects in PITP/ animals.
Purkinje cells normally align themselves into a sharply defined
monolayer that lies between the molecular and external gran-
ular layers of the cerebellum (Fig. 3B). These cells elaborate
well developed apical dendritic stalks which arborize into lux-
urious branches that penetrate into the molecular layer of the
cerebellum. PITP/ Purkinje cells, while retaining normal
flask-shaped cell body morphologies, exhibit either abbreviated
apical dendritic stalks or no obvious stalks at all (Fig. 3B).
Moreover, the dendritic branches emanating from the abbrevi-
ated apical stalks are less arborized than those of PITP/
Purkinje cells. We also observed cases where these cells exhibit
defects in spatial alignment, reside off of the defined layer, or
are otherwise misoriented.
Degenerative Disease in PITP/ Cerebellum—PITP/
cerebellum suffered major degenerative insult as judged by the
extent of reactive gliosis. Wild-type cerebellum shows low lev-
els of GFAP, a specific marker for activated astrocytes (Fig.
3C). By contrast, PITP/ cerebellum exhibits a dramatic
staining for GFAP, and reactive gliosis is especially prominent
in the white matter trunk of this organ (Fig. 3C). Even in these
relatively less affected areas, GFAP immunohistochemistry
suggests some 10% of the cells represent activated astrocytes
that are frequently seen to be enveloping neuron cell bodies
(Fig. 3D). Reactive gliosis is not observed throughout the mu-
tant brain. Whereas PITP/ cerebellum and brain stem are
heavily infiltrated with activated glial cells, and the subtha-
lamic region is also involved, significant gliosis is not observed
in the neocortex, striatum, hippocampal formation, and other
forebrain regions (not shown).
Finally, electron microscopy reveals ER defects in cerebellar
neurons of PITP/ mice. These defects manifest themselves
as significant vacuolations of the smooth ER region, even
though adjacent regions of rough ER retain normal morphology
(not shown). Such vacuolations are not observed in smooth ER
of PITP/ cerebellar neurons.
Neurodegeneration and Inflammation in PITP/ Spinal
Cord—We consistently observed WM deficits in PITP/ cer-
vical, thoracic, and lumbar spinal cord. Whereas ventral WM is
well developed in PITP/ cervical spinal cord, the corre-
sponding WM regions are thin and sparse in PITP/ ani-
mals (Fig. 4A). WM to GM area ratios in cervical spinal cord are
0.45 	 0.1 for PITP/ and 0.32 	 0.02 for PITP/ mice,
respectively (p 
 0.01; n  6). In addition to the WM deficits,
evidence of inflammation pervades all regions of the PITPa/
spinal cord. Toluidine blue O-staining reveals areas of abnor-
mally heavy staining in the ventral horn where motor neuron
cell bodies reside, suggesting cell damage in these areas (Fig.
4A). Moreover, whereas the WM/GM interface of PITP/
cervical spinal cord presents normal vascular structures, neu-
rons, and accessory cells, corresponding regions of the
PITP/ spinal cord exhibit densely stained cells and dam-
aged neurons (Fig. 4B). These pathologies encompass a spec-
trum of cell death events. These range from occasional apop-
totic neurons (condensed nuclei, fragmented cytoplasm; not
shown) to large numbers of neurons undergoing aponecrotic
processes (Fig. 4B). Aponecrosis is a form of cell death associ-
ated with reductions in cellular ATP and increases in ADP
levels (27, 28). Analyses from six PITP/ mice indicate that
18 	 1% of the total motor neuron cell bodies in the ventral
horn exhibit properties of aponecrosis. These include pericyto-
plasmic vacuolation, reduced cytoplasmic contents, and cyto-
plasmic proliferation of irregular electron-translucent vesicles
(Fig. 4B).
We did not observe aponecrotic motor neurons in the ventral
horn of PITP/ spinal cord. Extensive vacuolation and mem-
brane blebbing is prevalent in cells that line the vasculature of
PITP/ spinal cord (not shown). Axons surrounding capil-
laries and small vessels in the GM are enlarged and often
damaged. This is unlikely to represent a perfusion artifact, as
this phenotype was not recorded in any of the spinal cord
sections analyzed from 14 PITP/ mice.
Toluidine blue O-staining reveals the presence of cells con-
taining an abundance of purple intracellular granules in the
perivascular matrix (Fig. 4C, left panel). This obvious purple
metachromasia is diagnostic of inflammatory mast cells (29, 30).
Accordingly, we find extratissular macrophages in perivascular
tissue or even in the vessels themselves (Fig. 4C, right panel),
suggesting the blood/brain barrier of PITP/ mice is itself com-
promised. Finally, spinocerebellar injury in PITP/ mice also
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includes processes that resemble those of other myelin-related cen-
tral nervous system inflammatory disorders (31). First, macro-
scopic swelling in the dorsal spinal columns is apparent. The non-
neuronal area (neuropil) comprises 54 	 3% in PITP/ spinal
cord (n  6; p  0.01) and 70 	 6% of total area in PITP/ spinal
cord, respectively. Degenerative processes in neuropil, typified by
swollen axons lacking organelles and cytoskeletal filaments, are
also obvious (not shown). Second, demyelination is scored in both
WM and GM areas of PITP/ mice and especially in the dorsal
spinal columns. Supporting cells that may be remodeling myelin
are also observed (Fig. 4D).
The fragility of the mutant central nervous system notwith-
standing, a variety of PITP/ neurons are amenable to pri-
mary culture. Cultured cortical neurons, cerebellar granule
cells, and spinal cord dorsal root ganglion neurons from
PITP/ mice are not more fragile than their PITP/
counterparts in any obvious way. Indeed, titration of nerve
growth factor concentrations from 50 to 5 ng/ml revealed no
differences in the thresholds of trophic factor required to sus-
tain viability of PITP/ versus PITP/ dorsal root gan-
glion neurons in culture (not shown). PITP/ cerebellar
granule cells are similarly robust. These data suggest a signif-
icant cause of neuronal injury in PITP/ mice is a hostile
physiological environment, rather than some overriding cell
autonomous defect.
Lipid Dysregulation in PITP/ Enterocytes—Failure of
PITP/ mice to thrive suggests a malabsorption disorder.
Histological analyses of duodenum indicate the architecture of
this organ and its muscle layers are similar in PITP/ and
PITP/ mice. Moreover, intestinal motility also appears nor-
mal (not shown). There are obvious anomalies in PITP/
intestinal epithelium, however. Most strikingly, PITP/ en-
terocytes exhibit an obviously heavy impregnation with the
lipophilic agent osmium relative to PITP/ enterocytes (Fig.
5A). These histological properties are consistent with an abnor-
mal accumulation of intracellular lipid in mutant enterocytes.
If the accumulated lipid is derived from dietary fat, rather than
manifestation of some other cellular pathology, active feeding
is expected to be required for the loading of mutant enterocytes
with lipid. Indeed, enterocytes harvested from PITP/ mice
subjected to a 10-h fast are clear of accumulated lipid (not
shown).
Closer inspection of PITP/ duodenal enterocytes by elec-
tron microscopy demonstrates that these cells contain a heter-
ogeneous population of lipid bodies (Fig. 5B). Even at this high
resolution, these structures stain with osmium in a manner
consistent with a lipid interior, and these vesicles exhibit an
average diameter of 300–700 nm. Inspection of the borders of
these lipid bodies at very high magnifications reveals a classi-
cal trilaminar membrane surrounding these structures (not
shown). PITP/ enterocytes, on the other hand, are packed
with vesicles that are also membrane-enclosed but are much
FIG. 3. Cerebellar injury in PITP-deficient mice. A, TUNEL staining of cerebellum. Genotypes are indicated. The ApopTag Fluorescein in
Situ Detection Kit (Intergen Co.) was used as instructed by the manufacturer. B, Purkinje cell defects in PITP/ cerebellum. The Purkinje cell
layer was revealed by staining with calbindin antibodies and counterstaining with toluidine blue O. C, reactive gliosis in PITP/ cerebellum.
Sagittal sections of PITP/ and PITP/ cerebellum (as indicated) were stained with anti-GFAP antibodies with or without counterstaining
with toluidine blue O (right and left columns, respectively). D, higher magnification images of PITP/ and PITP/ cerebellum stained with
anti-GFAP antibodies and counterstained with toluidine blue O. Genotypes are at top.
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FIG. 4. Neurodegenerative and inflammatory changes in PITP/ spinal cord. A, complete spinal cord sections were generated by
reconstructing images from 2-m-thick, epoxy resin-embedded sections of PITP/ stained with toluidine blue O (left, number of images n  30)
and PITP/ spinal cord (right, n  22). Bars are 0.15 mm. B, images from the ventral interface between gray and white matter (GM/WM
interface) of cervical spinal cord sections. Top panels, representative images of PITP/ motor neuron cell bodies (left, open arrows) and
abnormally dark staining PITP/ motor neuron cell bodies (right, dark arrows) are indicated. Bars are as follows: left, 50 m; right, 100 m.
WM regions are indicated. Bottom panels, additional images from GM/WM interface of PITP/ cervical spinal cord are shown. Characteristic
neurodegenerative symptoms include highly vacuolated cells (center panel, solid arrow), dark cells (right panel, solid arrows), and abnormally
lightly stained cells without discrete intracellular structure (right panel, *). Bars are as follows: left, 100 m; center, 50 m; right, 20 m. C,
inflammatory cells in PITP/ thoracic spinal cord. Left panel, mast cell (MC) and capillary lumen (C) are indicated. Right panel, macrophage
(MF) and capillary lumen (C) are indicated. Bars are as follows: left, 20 m; right, 5 m. D, electron micrographs of myelin from the WM/GM
interface of PITP/ (left) and PITP/ spinal cord (center). Examples of myelinated axons are indicated by arrows. Right panel, cells that may
be remodeling myelin are present in large numbers in PITP/ mice and an example is indicated (*). Bars are as follows: left, 15 m; center, 10
m; right, 6 m.
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FIG. 5. Accumulation of lipid in PITP/ duodenal epithelium. A, intracellular lipid in enterocytes of PITP/ duodenum. Sections (5
m thick) of duodenum from PITP/ and PITP/ P5 siblings were stained with osmium and counterstained with toluidine blue O. Black
granules identify lipid. Relevant genotypes are given. B, electron micrographs of duodenal epithelium from PITP/ (left) and PITP/ (right)
P8 mice are shown. Bars are 5 m. C, electron micrographs of enterocytes from PITP/ and PITP/ mice as indicated. Bars are 2 m. D,
electron micrographs of lipid bodies from PITP/ (left panels) and PITP/ enterocytes (right panels) as indicated. Dimensions of the lipid
bodies aside, the general morphologies of these structures exhibit many similarities in wild-type versus mutant enterocytes, and most are
membrane-enclosed. Boundary membranes are indicated by arrows. A cytoplasmic lipid droplet (L) with a fuzzy border is shown for contrast. Bars
are 0.2 m. E, distribution histogram of vesicle perimeters in PITP/ (solid symbols) and PITP/ mice (open symbols). Perimeter measure-
ments were made for 428 and 398 lipid bodies from PITP/ and PITP/ enterocytes, respectively. F, enlargement of smooth ER in PITP/
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larger than those observed in PITP/ enterocytes. Moreover,
the structures that accumulate in PITP/ enterocytes often
appear multilobed (Fig. 5C). Representative profiles of such
structures from PITP/ and PITP/ enterocytes are
shown at higher magnification in Fig. 5D. The size differences
of the structures in wild-type and nullizygous enterocytes not-
withstanding, these share many structural features. It is there-
fore likely that the biogenesis of the lipid bodies initially fol-
lows a common course in PITP/ and PITP/ enterocytes.
Morphometric measurements indicate a rather unimodal fre-
quency distribution of vesicle perimeters from PITP/ mice
(average is 2 m; Fig. 5E). By contrast, the accumulated
structures in PITP/ enterocytes are much larger and have
multimodal size distributions. Perimeters of 20 m are often
observed, and perimeters in excess of 50 m are also encoun-
tered (Fig. 5E). Finally, our results indicate that the lipid
structures in PITP/ enterocytes reside predominantly in
dilated regions of smooth ER (Fig. 5F).
-Tocopherol and Plasma TG Deficiency in PITP/ Mice—
The failure of PITP/ mice to thrive, when coupled with
their retention of lipid in the enterocyte smooth ER, predicts a
malabsorption-mediated deficit in fat-soluble vitamins, partic-
ularly -tocopherol (vitamin E), and reduced levels of post-
prandial plasma TGs. We find PITP/ mice are deficient in
-tocopherol. Whereas PITP/ brain exhibits 19.48 	 3.41
g of -tocopherol/gm tissue, values for PITP / brain are
10-fold reduced (2.11 	 0.04 g of -tocopherol/g of tissue;
Fig. 5G). Post-prandial plasma TG levels in PITP/ mice are
also 3-fold reduced relative to PITP/ mice (55 	 13 versus
183 	 15 mg/dl).
By contrast, PITP/ and PITP/ plasma cholesterol
levels are similar. Indeed, comprehensive blood chemistry
analyses demonstrate many (although not all) parameters are
largely normal for PITP/ mice (Table I). Immunoblot ex-
periments indicate that apolipoprotein B48 and microsomal
triglyceride transfer protein, two components required for chy-
lomicron assembly, are expressed in PITP/ mice and that
serum apoB levels are similar to those recorded for PITP/
mice (not shown).
PITP/ Mice Exhibit Microvesicular Steatosis in Liver—
The pathways for lipid transport from the ER lumen to the cell
surface are similar in enterocytes and hepatocytes. In that
regard, PITP/ liver also exhibits obvious microvesicular
steatosis, as evidenced by its dramatically enhanced staining
with osmium (Fig. 6A) and with the lipophilic dye Oil Red O
(Fig. 6B). Because Oil Red O exhibits specific affinity for neu-
tral lipids (e.g. TG, DAG, and CE), we conclude that the accu-
mulated lipid is largely of the neutral class. These histochem-
ical data are extended by electron microscopy. Relative to wild-
type hepatocytes, PITP/ cells exhibit an abundance of large
intracellular lipid bodies. We often detect such structures in
the nuclear matrix of mutant hepatocytes, a circumstance we
have yet to encounter in wild-type cells (Fig. 6C).
The lipid bodies are either membrane-bound or represent
large cytoplasmic lipid droplets (Fig. 6D). Unlike in mutant
enterocytes, where accumulated lipid is predominantly found
in membrane-enclosed compartments, 60% of the lipid bodies
in PITP/ hepatocytes represent what we interpret to be
cytosolic lipid droplets due to lack of identifiable boundary
membrane (Fig. 6D). This raises the possibility that the mech-
anism of hepatic steatosis differs from that of the PITP/
enterocytes. Although we cannot yet exclude the possibility
that allocation of fatty acids and lipids between storage pools
and lipoprotein pools is deranged in PITP/ liver, at least
some key fatty acid and lipid biosynthetic enzymes (acetyl-CoA
carboxylase, stearyl-CoA reductase, and fatty-acid synthase)
are not transcriptionally up-regulated in this mutant tissue
(not shown). Moreover, the hepatic microvesicular steatosis,
although qualitatively resistant to a short 6-h fast, is reversed
by fasting mutant mice for 17 h (not shown).
Quantitative Analyses of Lipids and Fatty Acids in
PITP/ Liver and Brain—The lipid derangement in
PITP/ duodenum and liver suggests increased neutral
lipid mass. To test this interpretation directly, the mass of a
variety of lipid species in PITP/ and PITP/ liver and
brain was quantified. The intestine provides technical chal-
lenges in this assay as the mice analyzed are neither fasted nor
germ-free. We assume analysis of liver lipid mass is generally
representative of the situation in intestine.
As shown in Fig. 7A, although the relative TG, DAG, and CE
contents are very similar in matched wild-type and PITP
nullizygous brain tissue, bulk neutral lipid mass is dramati-
cally elevated in PITP nullizygous liver. Bulk TG and FFA
mass is 2.0- and 2.6-fold increased relative to the respective
values recorded for wild-type liver. Bulk CE and DAG mass is
also increased in PITP/ liver. Unexpectedly, PITP/
brain exhibits a 3.3-fold increase in FFA mass relative to
PITP/ brain (Fig. 7A).
The derangements in neutral lipid/FFA content in PITP/
tissues do not reflect a universal derangement of lipid homeo-
stasis. PtdCho, phosphatidylethanolamine, and phosphatidyl-
serine mass values are similar in matched wild-type and PITP
nullizygous brain and liver tissue (Fig. 7B). We do note, how-
ever, that mass of specific polar lipids such as sphingomyelin
and lyso-PtdCho are elevated in PITP nullizygous brain, and
TABLE I
Serum analyses
Serum pooled from six PITP/ and PITP/ mice each, varying in
age from P6 to P9, were subjected to a comprehensive mammalian
chemistry panel performed by Antech Diagnostics (Farmingdale, NY).
Values represent the averages of triplicate measurements obtained
from three different sets of mice. Parameters that differ significantly
between PITP/ and PITP/ mice are highlighted at top of the
table. The abbreviations used are: APase, alkaline phosphatase; AST,
aspartate aminotransferase; CPK, creatinine phosphokinase; ALT, al-
anine aminotransferase.
Parameter PITP/ PITP/
Bilirubin 0.84 	 0.16 mg/dl 1.54 	 0.10 mg/dl
APase 809 	 160 units/liter 1497 	 179 units/liter
AST 135 	 9 units/liter 250 	 18 units/liter
CPK 4892 	 42 units/liter 6439 	 147 units/liter
Creatinine 0.44 	 0.08 mg/dl 0.44 	 0.08 mg/dl
Total protein 3.10 	 0.34 g/dl 3.10 	 1.33 g/dl
ALT 52.4 	 18.3 units/liter 46.1 	 13.2 units/liter
Albumin 1.70 	 0.18 g/dl 1.60 	 0.17 g/dl
Cholesterol 134 	 14 mg/dl 137 	 11 mg/dl
Calcium 7.04 	 0.24 mg/dl 8.28 	 1.70 mg/dl
Phosphorus 11.4 	 1.5 mg/dl 11.3 	 1.3 mg/dl
Sodium 115 	 14 Meq/liter 113 	 8 Meq/liter
Potassium 7.2 	 1.2 Meq/liter 7.3 	 0.9 Meq/liter
Chloride 50.6 	 11.9 Meq/liter 45.3 	 3.0 Meq/liter
Globulin 1.20 	 0.25 g/dl 1.50 	 32 g/dl
Urea N2 22.0 	 5.0 mg/dl 25.0 	 7.5 mg/dl
duodenal enterocytes as revealed by electron microscopy. Lipid-engorged regions are identified by arrows. These smooth ER luminal regions are
contiguous with the lumen of adjacent rough ER that is easily recognized by the associated ribosomes (not shown). Bar is 0.4 m. G, PITP/
mice exhibit reduced brain -tocopherol and post-prandial TG levels. Parameters are indicated. Measurements were made from nine PITP/ and
nine PITP/ mice. Averages 	 S.D. are given.
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CL levels are altered in both mutant brain and liver relative to
matched wild-type tissues (Fig. 7C).
Fatty acid compositions of the CE, DAG, TG, FFA, sphingomy-
elin, and CL pools of PITP/ and PITP/ brain (Table II)
and liver (Table III) were also compared. The most striking
qualitative and quantitative difference is the reduced content of
18:2n6 (9,12-octadecadienoic acid) in mutant brain TG, DAG, and
CL pools (Table II), and an increase in 18:1n9 (9-octadenoic acid)
in CE, DAG, and FFA pools in nullizygous liver (Table III). Fatty
acid profiles of brain and liver lyso-PtdCho were determined for
PITP/ and PITP/ mice, and no differences were scored
(not shown).
Reduced ATP Content in PITP/ Cerebellum and Liver—
Electron microscopic analyses reveal not only lipid accumula-
tion but also indications of aponecrosis in mutant hepatocytes.
These indications resemble those observed in the PITP/
spinocerebellar system (see above) and include the significantly
increased proliferation of electron-dense autophagic bodies
throughout the cytoplasm (cytolysosomes) and regions of di-
lated smooth ER (not shown). Aponecrosis in the spinocerebel-
lar system and in liver suggests a fundamental defect in energy
metabolism in PITP nullizygous mice. Indeed, ATP levels are
diminished in PITP/ relative to PITP/ liver (40.4 	 8.6
versus 98.1 	 9.3 pmol of ATP/mg of tissue; Fig. 8A). ATP/ADP
ratios further emphasize this reduction (2.8 	 0.5 for
PITP/ and 9.1 	 3.1 for PITP/ liver; Fig. 8B). Simi-
larly, PITP/ and PITP/ animals exhibit 83.3 	 5.3 and
44.9 	 5.9 pmol of ATP/mg of cerebellum, respectively (Fig. 8A).
Reduced cerebellar ATP/ADP ratios are measured as well
(7.7 	 1.0 for wild-type versus 4.2 	 0.5 for mutant; Fig. 8B).
Interestingly, PITP/ and PITP/ brain ATP levels (40 	
59 and 343 	 65 pmol of ATP/mg of brain, respectively) and
ATP/ADP ratios (13.6 	 2.3 versus 9.1 	 0.7, respectively) are
comparable, thereby regionally correlating neuronal and he-
FIG. 6. Microvesicular steatosis in PITP/ hepatocytes. A, liver sections from PITP/ and PITP/ P5 siblings were stained with
osmium and counterstained with toluidine blue O. Black granules identify lipid. Relevant genotypes are given at left. B, liver sections from mice
of the indicated genotype were stained with Oil Red O and counterstained with hematoxylin/eosin. The red globules prevalent in sections of PITP
nullizygous liver identify neutral lipid bodies. C, electron micrographs of PITP/ and PITP/ liver sections are shown. Nuclei (N) and
examples of lipid bodies are highlighted by arrows. Bars (clockwise from upper left) are 2, 2, 3, and 2 m, respectively. D, electron micrograph of
lipid bodies that accumulate in PITP nullizygous hepatocytes. The right panel is a magnification of the region identified by the box in the left
panel. One lipid body is membrane-enclosed (arrow), whereas the other lacks a distinct border and is interpreted to represent a large cytoplasmic
lipid droplet. Bars (from left) are 2 and 0.4 m, respectively.
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patic injury with reduced cellular ATP (Fig. 8, A and B). The
significant decrease in mass of the mitochondrial lipid CL in
PITP/ liver is consistent with energetic compromise (Fig.
7C). The mass increase of CL in PITP/ brain may reflect
compensatory attempts by this tissue to enhance mitochondrial
activity in response to an unfavorable energy status (Fig. 7C).
Hypoglycemia in PITP/ Mice—The aponecrotic cell
death observed in the PITP/ spinocerebellar system and
liver diagnoses a systemic problem. In this regard, we find
PITP/ neonates are severely hypoglycemic. We measure
9-fold reductions in serum glucose levels of PITP/ mice
(9.6 	 3.6 mg/dl) relative to PITP/ siblings (88.0 	 6.6
mg/dl serum; Fig. 9A). This reduction in serum glucose is of
similar magnitude to that measured for PITP/ mice that
are fasted overnight, despite the fact that stomachs of all
PITP/ mice analyzed were filled with milk at the time of
analysis (not shown).
Reduction in serum glucose is not secondary to hyperinsu-
linemia. Circulating insulin levels in PITP/ mice are 9-fold
lower than those of PITP/ siblings (0.5 	 0.2 versus 4.5 	
0.2 ng/ml, respectively; Fig. 9A). Given the hypoglycemia of
PITP/ mice, these low insulin levels are appropriate (see
below). We also measured an increase in circulating -hydroxy-
butyrate in PITP/ versus PITP/ serum (19.1 	 1.2 and
11.2 	 1.8 mg/dl, respectively; Fig. 9A), and this increase is
recapitulated in serum of PITP/ mice that were fasted
overnight (20.2 	 0.1 mg/dl). -Hydroxybutyrate is generated
by mitochondrial oxidation of fatty acids and serves as an
alternative energy source for hypoglycemic tissue. Modest ele-
vations are scored for bilirubin and alkaline phosphatase in
PITP/ mice (consistent with modest hepatic stress), and a
2-fold increase in the gluconeogenic enzyme aspartate ami-
notransferase is also measured (Table I).
Reduced Proglucagon Gene Expression in PITP/ Mice—
Mice normally effect dramatic changes in circulating insulin,
corticosteroid, and glucagon levels to activate hepatic glucone-
ogenesis late in gestation. This reprogramming of hormonal
signaling serves as a protective mechanism for the impending
loss of the glucose source provided by the maternal circulatory
system in utero (33). Mutant animals are appropriately re-
sponding to hypoglycemia as evidenced by elevated levels of
circulating corticosteroids, a hormonal stimulus for gluconeo-
genesis. Levels of plasma corticosteroid are highly elevated in
PITP/ mice relative to PITP/ littermates (51.64 versus
19.58 ng/ml, respectively). We also compared expression of the
gluconeogenic enzymes Glc-6-Pase and phosphoenolpyruvate
carboxykinase in PITP/ and PITP/ mice. Expression of
both genes in PITP / liver compares favorably to PITP/
control as their corresponding mRNA levels in PITP/ liver
are 1.3 	 0.1- and 1.1 	 0.2-fold increased relative to those of
PITP/ liver (Fig. 9B). Thus, transcriptional control of key
gluconeogenic enzymes also appears intact in the mutant mice.
Elevated serum levels of the gluconeogenic enzyme aspartate
aminotransferase in PITP/ further support this conclusion
(Table I).
By contrast, proglucagon gene expression is inappropriately
depressed in PITP/ animals (Fig. 9B). By using -actin
mRNA as a normalizing factor, proglucagon gene expression in
pancreas is reduced 11.7 	 0.1-fold in PITP/ mice relative
to PITP/ siblings. In independent agreement with the
Northern data, we record a 5-fold reduction in circulating glu-
and hatched bars, respectively. Numerical values for each bar are given.
A, neutral lipid mass measurements. B, polar lipids whose mass is
unaltered in PITP/ versus PITP/ tissues. C, polar lipids whose
mass is altered in PITP/ versus PITP/ tissues. SM, sphingomy-
elin; PtdEtn, phosphatidylethanolamine; PtdSer, phosphatidylserine.
FIG. 7. Quantification of lipid mass in PITP/ and PITP/
brain and liver. Brains and livers were collected from each of four
freshly euthanized non-fasted PITP/ and PITP/ mice and com-
bined to generate defined tissue pools for each genotype. Pools were
frozen and quantified for individual lipid species and FFAs via the
Lipomics Technologies, Inc., TrueMassTM protocol. Individual lipid spe-
cies are given at the top, and brain and liver values for each lipid species
are given in a vertical column below each heading. Brain values are
represented in the top panels, and the liver values are in the bottom
panels as indicated. All lipid species are quantified as nanomoles per g
of tissue. PITP/ and PITP/ values are indicated by solid bars
Ablation of PITP Function in Mice 33511
cagon levels in mutant animals (246.68 and 49.32 pg of gluca-
gon/ml of plasma for PITP/ and PITP/ mice,
respectively).
Glycogen Metabolism in PITP/ Mice—Normally, liver
glycogen is rapidly consumed in response to hypoglycemia.
Reductions in plasma glucagon therefore predict defects in
glycogenolysis in PITP/ mice. Periodate acid-Schiff stain-
ing and visualization of glycogen rosettes by electron micros-
copy indicate substantial and inappropriate glycogen stores in
PITP/ liver (not shown). Quantitative analyses support
these observations. As expected, PITPa/ liver contains
109.0 	 15.3 mol of glycogen-derived glucose/g of tissue, and
liver glycogen stores are depleted by a 10-h fast (Fig. 9C).
Strikingly, the hypoglycemia of the mutant mice notwithstand-
ing, PITPa/ liver contains 107.0 	 12.2 mol of glycogen-
derived glucose/g of tissue (Fig. 9C). This compares favorably to
wild-type values.
To characterize further the derangement in glycogen metab-
olism, we tested whether glycogen stores in PITP/ liver are
resistant to depletion by fast. We found that a 10-h fast evokes
complete depletion of glycogen from mutant liver (Fig. 9C).
When levels of liver glycogen are measured as a function of
duration of fast in PITP/ and PITP/ animals, we found
the rate of glycogen depletion from fasted PITP/ liver is
delayed. Whereas PITP/ mice deplete 50 and 70% of their
liver glycogen stores by 2 and 4 h of fast, respectively,
PITP/ mice effect only a modest 23 and 27% depletion in
liver glycogen stores after 2 and 4 h of fast, respectively (Fig.
9D). Taken together, these results are not consistent with an
absolute block in PITP/ liver glycogen catabolism. Rather,
the data indicate PITP/ liver exhibits kinetic defects in the
rate of glycogenolysis and additionally suggest an inappropri-
ate channeling of glucose to glycogen synthesis in the hypogly-
cemic mutant mouse.
Morphological Alterations in PITP/ Pancreas—Reduced
proglucagon gene expression could reflect specific derangement
of proglucagon gene expression in the mutant animals or could
arise indirectly from generalized pancreatic dysfunction. Al-
though exocrine pancreas morphologies of PITP/ and
PITP/ mice are similar, PITP/ pancreas exhibits obvi-
TABLE II
Acyl chain compositions of bulk brain lipids
Fatty acid compositions of the lipid classes analyzed from pooled brain tissue samples depicted in Fig. 7 were determined by Lipomics
TrueMass™ technology. Profiles of the indicated fatty acid species (at left) for the indicated lipid species (at top) are presented in nanomoles of fatty
acid/total moles of fatty acid in each lipid class. The data are presented as PITP/ value/PITP/ value. Some differences between correspond-
ing PITP/ and PITP/ values are indicated in boldfase. Omega fatty acid nomenclature is employed. The t prefix indicates trans-double bond,
and the dm prefix indicates plasmalogen-linked fatty acid. SM indicates sphingomyelin. A precise molecular description of each fatty acid species
analyzed is provided at www.lipomics.com/Fatty%20Acids/fatty_acid.htm.
Acyl species CE TG DAG FFA SM CL
14:0 5.4/6.0 3.3/0.0 4.1/5.4 4.1/4.2 2.6/3.5 1.9/2.0
14:1n5 0.0/0.0 0.7/1.0 0.0/0.0 0.0/0.0 0.1/0.2 0.0/0.0
15:0 1.0/1.6 1.6/2.8 0.8/1.1 1.3/1.0 0.5/1.1 1.2/1.7
dm16:0 1.7/3.3 0.7/1.3 0.0/0.4 0.0/0.3 0.2/0.3 2.6/3.1
16:0 23.2/21.4 27.2/28.5 28.9/36.0 33.4/33.9 17.1/16.8 16.1/16.9
t16:1n7 0.9/1.8 0.7/1.3 3.1/3.3 5.4/5.5 1.6/2.6 0.5/2.2
16:1n7 9.1/13.2 3.7/5.6 1.3/1.4 1.2/0.9 1.3/1.8 3.3/1.8
dm18:0 0.0/0.0 0.9/0.7 0.0/0.0 0.4/0.7 0.2/0.1 1.8/2.1
dm18:1n9 1.9/2.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.1/0.2
dm18:1n7 0.0/0.0 0.8/1.0 0.0/0.0 0.0/0.0 0.0/0.0 0.2/0.2
18:0 16.4/11.9 15.4/18.8 23.4/27.9 27.4/30.4 28.7/23.2 21.8/18.9
t18:1n9 0.0/0.0 0.0/0.0 0.0/0.4 0.0/0.0 0.3/0.9 0.0/0.0
18:1n9 12.3/11.5 17.3/18.2 15.2/8.7 12.2/10.7 18.4/25.0 6.0/6.0
18:1n7 0.6/0.0 1.5/1.2 1.6/1.0 1.5/1.3 1.7/1.7 2.1/1.5
t18:2n6 0.0/0.0 0.0/0.0 0.2/0.3 0.0/0.1 0.0/0.0 0.0/0.0
18:2n6 7.2/6.8 16.3/8.9 9.1/4.8 6.1/4.2 2.7/3.1 8.4/2.8
18:3n6 0.0/0.6 0.3/0.6 0.3/0.0 0.2/0.0 0.0/0.0 0.0/0.0
18:3n3 0.2/0.0 0.6/0.4 0.8/0.8 0.3/0.4 0.4/0.4 0.4/0.3
18:4n3 0.0/0.3 0.3/0.5 0.0/0.0 0.0/0.0 0.0/0.0 0.2/0.2
20:0 0.4/1.0 0.8/0.4 0.8/0.7 0.9/0.9 0.4/0.3 0.2/0.2
20:1n15 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0
20:1n12 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0
20:1n9 6.2/5.6 1.1/2.0 0.4/0.0 0.2/0.3 0.5/0.4 0.4/0.2
20:3n9 0.0/0.0 0.0/0.0 0.3/1.4 0.5/0.4 0.1/0.1 0.0/0.1
20:2n6 0.7/0.9 0.8/0.3 0.3/0.5 0.4/0.4 0.1/0.2 16.9/25.2
20:3n6 0.0/0.0 1.0/0.3 0.4/0.0 0.4/0.3 0.6/0.5 0.5/0.4
20:4n6 1.1/0.0 1.4/0.4 7.7/2.8 3.5/1.9 4.5/3.3 4.4/4.1
20:3n3 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.1 0.1/0.0
20:4n3 0.0/0.0 0.3/0.2 0.0/0.0 0.0/0.0 0.0/0.0 0.3/0.3
20:5n3 0.0/0.0 0.3/0.0 0.2/0.0 0.0/0.1 0.0/0.0 0.0/0.1
22:0 1.1/1.8 0.3/0.3 0.0/0.0 0.0/1.1 0.6/0.4 0.1/0.2
22:1n9 9.3/8.6 1.3/0.3 0.0/1.1 0.0/0.4 0.4/0.3 0.3/0.4
22:2n6 0.0/0.3 0.0/0.0 0.0/2.1 0.0/0.2 0.0/0.1 0.7/0.6
22:4n6 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.2/0.2 0.4/0.0
22:5n6 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0
22:5n3 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.6/0.4 0.1/0.2
22:6n3 0.0/0.0 0.3/0.3 1.1/0.0 0.0/0.0 15.9/12.4 8.5/7.3
24:0 1.3/1.5 0.8/0.3 0.0/0.0 0.5/0.6 0.2/0.3 0.2/0.4
24:1n9 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.2/0.4 0.2/0.3
24:6n3 0.0/0.0 0.2/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0
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ous structural defects in that pancreatic islets are not at all
prominent. Serial sectioning of PITP/ and PITP/ pan-
creas, and quantification of total islets in the organ, revealed a
greater than 2-fold reduction in absolute islet number in
PITP/ pancreas relative to wild type (Fig. 10A). In addition
to the significant reduction in the number of islets, the mor-
phology of identifiable islets in PITP/ pancreas is also
highly abnormal. Islet cells are sparse and shrunken, and large
vacuolations are abundant in the islets themselves (Fig. 10B).
The damage of pancreatic islets in PITP/ mice provides a
direct rationale for reduced proglucagon expression and defec-
tive gluconeogenesis in PITP/ animals. Moreover, the very
low levels of circulating insulin measured for PITP/ mice
(see above) may also result from islet -cell insufficiencies and
not simply from the hypoglycemic state of these animals.
PITP/ Cells Are Not Generally Defective in UPR—A link-
age between activation of UPR and survival of pancreatic se-
cretory islet cells has been demonstrated (34, 35). The ER
abnormalities in PITP-deficient enterocytes, hepatocytes, and
neurons, when coupled with loss of functional pancreatic islets
in mutant mice, suggested the possibility that PITP/ cells
are intrinsically defective in UPR.
First, we compared the response of PITP/ and PITP/
ES cells and MEFs to glucose deprivation. Cells defective in UPR
are sensitive to such a challenge (34). In neither case do we record
an unusual sensitivity of PITP/ cells to glucose deprivation.
PITP/ ES cells maintain levels of viability that are 71 	 5
and 55 	 8% of control after 42 and 72 h of glucose starvation,
respectively. The corresponding viability levels for isogenic
PITP/ ES cells are 71 	 4 and 54 	 10% (Fig. 10C).
Similarly, PITP/ MEFs exhibit viabilities of 82 	 5 and
73 	 10% after glucose deprivations of 42 and 72 h, respec-
tively. Isogenic PITP/ MEFs exhibit corresponding viabil-
ities of 84 	 4 and 76 	 8% (Fig. 10C).
Second, 35S-labeled amino acid pulse-radiolabeling experi-
ments demonstrate that treatment of PITP/ and isogenic
PITP/ ES cells with agents that activate UPR (i.e. dithio-
threitol) evoke reduced incorporation of 35S-labeled amino ac-
ids into nascent protein in both wild-type and mutant ES cells.
The rate of protein synthesis in the face of dithiothreitol is
7.2 	 0.7 and 5.2 	 0.7% of unchallenged control for PITP/
and PITP/ ES cells, respectively (Fig. 10D). This effect is a
result of a UPR-mediated translational block (34). These find-
ings are qualitatively reproduced in other experiments that
employed thapsigargin challenge to induce UPR (Fig. 10D).
Finally, we assessed whether challenge of PITP/ and
TABLE III
Acyl chain compositions of bulk liver lipids
Fatty acid compositions of the lipid classes analyzed from pooled liver tissue samples depicted in Fig. 7 were analyzed. See the legend to Table
II for essential details.
Acyl species CE TG DAG FFA SM CL
14:0 3.3/2.8 4.5/3.4 5.3/5.0 4.2/3.5 2.2/2.0 1.0/1.2
14:1n5 0.1/0.0 0.1/0.1 0.1/0.1 0.3/0.0 0.2/0.1 0.0/0.0
15:0 0.5/0.2 0.2/0.1 0.4/0.2 0.4/0.3 0.5/0.4 0.4/0.6
dm16:0 0.6/0.5 0.0/0.0 0.1/0.0 0.0/0.0 0.1/0.1 0.9/0.9
16:0 38.3/35.9 28.4/28.4 27.8/24.3 35.4/37.6 19.3/20.0 17.5/15.2
t16:1n7 1.0/0.5 0.4/0.5 1.0/0.8 1.4/1.2 1.0/0.5 0.6/0.6
16:1n7 5.3/5.8 2.1/1.8 1.6/1.6 1.7/1.2 1.7/1.4 0.7/0.9
dm18:0 0.0/0.1 0.1/0.1 0.0/0.0 0.1/0.1 0.0/0.0 0.3/0.3
dm18:1n9 0.8/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.1 0.1/0.1
dm18:1n7 0.1/0.4 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.1/0.1
18:0 9.5/5.8 4.1/3.3 9.0/6.2 9.4/10.5 22.5/22.3 15.9/14.5
t18:1n9 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.6/0.5 0.0/0.0
18:1n9 17.3/26.3 24.2/28.0 16.5/22.5 15.4/22.6 23.0/20.6 3.1/4.2
18:1n7 1.0/1.4 2.1/2.7 1.8/2.2 1.8/2.8 1.5/1.5 3.1/3.9
t18:2n6 0.1/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.1/0.2 0.0/0.0
18:2n6 11.5/11.8 21.8/23.4 18.9/23.2 15.8/12.1 5.0/4.5 29.5/36.9
18:3n6 0.3/0.3 0.4/0.4 0.4/0.5 0.2/0.1 0.1/0.1 0.1/0.1
18:3n3 0.7/0.6 0.6/0.4 0.8/0.7 0.5/0.1 0.5/0.4 0.5/0.4
18:4n3 0.0/0.0 0.1/0.1 0.0/0.1 0.0/0.0 0.0/0.0 0.0/0.0
20:0 0.2/0.1 0.1/0.0 0.3/0.2 0.2/0.2 0.3/0.5 0.1/0.2
20:1n15 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0
20:1n12 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0
20:1n9 0.3/0.2 0.6/0.5 0.2/0.4 0.3/0.6 0.4/0.3 0.1/0.3
20:3n9 0.0/0.0 0.2/0.2 0.3/0.3 0.2/0.4 0.0/0.0 0.0/0.1
20:2n6 0.4/0.2 0.7/0.6 0.7/0.6 0.9/1.0 0.2/0.2 6.6/3.6
20:3n6 0.8/0.6 1.0/0.7 1.0/1.0 1.2/0.7 0.8/0.9 0.6/0.6
20:4n6 3.2/2.7 2.4/1.5 4.5/3.7 7.3/4.0 9.8/11.2 5.6/5.2
20:3n3 0.0/0.0 0.0/0.0 0.1/0.1 0.1/0.0 0.1/0.1 0.1/0.1
20:4n3 0.2/0.0 0.1/0.0 0.1/0.1 0.1/0.0 0.0/0.0 0.1/0.1
20:5n3 0.4/0.3 0.3/0.2 0.4/0.3 0.5/0.1 0.4/0.4 0.3/0.2
22:0 0.3/0.3 0.0/0.0 0.1/0.0 0.0/0.0 0.6/0.4 0.1/0.1
22:1n9 1.3/0.9 0.2/0.1 0.0/0.1 0.1/0.2 0.4/0.2 0.6/0.4
22:2n6 0.0/0.0 0.1/0.0 0.0/0.2 0.1/0.1 0.0/0.0 0.0/0.0
22:4n6 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0
22:5n6 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0
22:5n3 0.2/0.1 1.0/0.4 1.0/0.7 0.0/0.4 0.7/0.7 0.3/0.3
22:6n3 1.8/1.5 4.1/1.7 7.6/5.1 1.6/0.2 6.4/7.2 11.4/8.7
24:0 0.6/0.5 0.1/0.1 0.0/0.0 0.3/0.1 0.3/0.6 0.1/0.1
24:1n9 0.1/0.0 0.0/1.0 0.0/0.0 0.0/0.0 1.3/2.6 0.1/0.1
24:6n3 0.0/0.0 0.2/0.2 0.0/0.0 0.0/0.0 0.0/0.0 0.0/0.0
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PITP/ MEFs and ES cells with the UPR-activating agent
tunicamycin leads to a differential response in expression of
the ER stress-induced transcription factor CHOP and the chap-
erone protein calnexin. Expression of these two polypeptides is
potently enhanced by induction of the UPR. Thus, CHOP and
calnexin serve as reliable reporters of the UPR status in cells.
As shown in Fig. 10E, CHOP is normally expressed at very low
levels in PITP/ and PITP/ MEFs, but challenge with
tunicamycin evokes a robust induction of CHOP expression in
MEFs of either genotype. Similarly, calnexin levels increase in
both PITP/ and PITP/ MEFs upon tunicamycin chal-
lenge (Fig. 10E). Congruent results are recorded with
PITP/ and PITP/ ES cells (not shown). We conclude
PITP/ cells are not only competent for induction of UPR
but that the nullizygous cells are not subject to constitutive
activation of the UPR.
DISCUSSION
Loss of PITP activity in mice manifests itself in spinocere-
bellar disease characterized by reactive gliosis of the cerebel-
lum and brain stem and WM and GM deficits in spinal cord.
The spinal cord pathologies include infiltration by inflamma-
tory cells, aponecrosis of motor neuron cell bodies in the ventral
horn, and pervasive demyelination that is particularly appar-
ent in the dorsal columns. PITP is also required for proper
absorption of dietary fat and fat-soluble vitamins through du-
odenal enterocytes into the circulation and for proper lipid
homeostasis in the liver. Finally, PITP/ mice are severely
hypoglycemic. The hypoglycemia is associated with reduced
proglucagon gene expression, compromise of pancreatic islet
integrity, and defects in liver glycogen metabolism. These find-
ings suggest unanticipated roles for PITP in signaling path-
ways that interface with trafficking of luminal lipid cargo from
the ER and glucose homeostasis in mammals.
PITP and Neonatal Survival—The development of
PITP/ mice to term supports our finding that PITP-defi-
cient ES cells maintain pluripotency and competence for mem-
brane trafficking and growth factor signaling (17). Rather, the
neonatal mortality of PITP/ mice indicates a role for PITP
in regulating physiological functions that are critical in the
context of the whole mouse. We conclude PITP nullizygosity
manifests itself primarily upon extinction (by birth) of the
nutritional resource provided by maternal circulation in utero,
and reliance of the neonate on assimilation of its own dietary
intake.
PITP Deficiency and Steatosis—The most energy-rich com-
ponent of the neonatal diet is TG, and the evidence suggests
PITP/ mice are unable to effectively avail themselves of
this nutrient source. In mammals, long chain TGs of maternal
milk are hydrolyzed to monoacylglycerols and fatty acids.
These compounds are transported across the apical enterocyte
plasma membrane and reassembled into TG cores in the
smooth ER lumen. The TG cores are then co-assembled with
other lipids, fat-soluble vitamins, and apolipoproteins into chy-
lomicrons either in the ER or in the Golgi complex. Subse-
quently, chylomicrons are transported across the enterocyte
basolateral plasma membrane via the secretory pathway (37).
Enterocytes and hepatocytes share analogous pathways for
assembly and secretion of lipoproteins into the circulation. The
suckling-dependent microvesicular steatosis of PITP/ in-
testine and liver suggests that PITP plays a common role in
both intestinal and hepatic pathways for secretion of dietary
lipids. A failure in transport early in the secretory pathway is
indicated as electron microscopy suggests neutral lipids accu-
mulate in smooth ER of PITP nullizygous enterocytes and in
hepatocytes.
The intestinal steatosis of PITP/ mice exhibits similari-
ties with human CRD, a family of autosomal recessive disor-
ders. Human CRD patients are characterized by pediatric
failure to thrive, accumulation of chylomicrons within villus-
associated enterocytes of the duodenum, reductions in post-
prandial plasma TG and -tocopherol levels, and spinocerebel-
lar involvement (18, 19, 32, 38). Similarly, PITP/ mice gain
body mass slowly and are deficient in body fat. Moreover,
villus-associated PITP/ enterocytes accumulate intracellu-
lar lipid in a suckling-dependent manner. Finally, PITP/
mice exhibit large reductions in both post-prandial plasma TG
and in brain -tocopherol. These data suggest PITP/ mice
hydrolyze dietary TG in the lumen of the duodenum, transport
the products into the enterocyte, and properly reassemble die-
tary TG in the ER lumen but are defective in transport of
re-esterified TGs across the PITP/ enterocyte to the baso-
lateral plasma membrane. The microvesicular hepatic steato-
sis we observe in PITP/ mice is not a symptom associated
with human CRD, however.
PITP Deficiency and Glucose Homeostasis—PITP/ neo-
nates are hypoglycemic, even though key gluconeogenic en-
zymes appear to be expressed normally. However, gluconeogen-
esis is an energetically expensive process as 4ATP, 2GTP,
2NADH, and 4H2O are consumed in conversion of 2 pyruvate
units to 1 glucose molecule (39). Fatty acid oxidation is a potent
engine that drives production of the ATP, GTP, and NADH
utilized in glucose synthesis and is also involved in production
FIG. 8. Tissue-specific energy deficits in PITP/ mice. A, tis-
sue ATP levels in PITP/ mice. Measurements were averaged for
three determinations from each of three independent P4-P6 PITP/
(solid bars) and PITP/ animals (hatched bars). B, ATP/ADP ratios
for the indicated tissues. ADP was measured indirectly by conversion to
ATP and measurement of ADP-derived ATP. No significant differences
in ATP or ATP/ADP ratio were observed between measurements of
cerebellar hemispheres, or selected brain or liver regions, and those of
whole-organ homogenates. PITP/ and PITP/ data are in solid
and hatched bars, respectively.
Ablation of PITP Function in Mice33514
of ketone bodies that serve as energy sources under conditions
of low glucose availability. We suggest that the inability to
effectively deliver lipid from enterocytes and hepatocytes to
peripheral tissues imposes a heavy metabolic burden on
PITP/ neonates by compromising fatty acid oxidation as a
pathway for powering both gluconeogenesis and ketone produc-
tion. Reductions in PITP/ liver ATP are consistent with
this interpretation of the data.
In addition, PITP/ animals exhibit kinetic defects in
glycogenolysis, and these maintain substantial liver glycogen
in the face of hypoglycemia. These defects coincide with dra-
matic reductions in proglucagon gene expression in PITP/
pancreas. Presently, we do not believe that dysregulation of
proglucagon expression reflects a direct transcriptional in-
volvement of a nuclear PITP pool in regulating proglucagon
promoter function. Rather, we hypothesize that glucagon defi-
cit in PITP/ mice more likely represents an indirect man-
ifestation of the structurally compromised endocrine pancreas
that characterizes such mutants. Yet, because the glycogen
stores of PITP/ liver are consumed during a modest fast,
we conclude that regulation of glucose allocation into the gly-
cogen synthesis pathway must also be deranged in PITP/
mice.
PITP Deficiency and Integrity of the Spinocerebellar Sys-
tem—PITP/ neonates develop a spinocerebellar neurode-
generative disease characterized by aponecrotic cell death. In
this regard, we find a correlation between site of neuronal
injury and regional specificity of dramatic reduction in cellular
FIG. 9. Hypoglycemia in PITP/ mice. A, serum glucose, insulin, and -hydroxybutyrate levels. Serum was collected from age-matched
PITP/ (closed bars) and PITP/ (hatched bars) mice. Glucose data are averaged from six age-matched PITP/ and PITP/ mice of each
genotype. Serum insulin and -hydroxybutyrate values represent averages of triplicate measurements obtained from three mice of each genotype.
Values from fasted PITP/ mice (18 h) are indicated by F. B, Glc-6-Pase, phosphoenolpyruvate carboxykinase (PEPCK), and -actin mRNA levels
in PITP/ and PITP/ liver, and proglucagon and -actin mRNA levels in pancreas. Data are representative of at least three independent
mRNA extractions and hybridizations. RNA load was normalized to 10 g total mRNA per lane, and the -actin data serve as indicators of
normalization quality. C, glycogen was quantified for non-fasted and fasted PITP/ and PITP/ liver, as indicated. D, kinetics of liver
glycogen depletion. Age-matched PITP/ () and PITP/ () mice with stomachs full of milk were fasted as indicated, sacrificed, and liver
glycogen measured. Mean glycogen values are given for PITP/ and PITP/ liver as solid and open bars, respectively, and statistical
significance of the mean differences is given above each data set.
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ATP. Neonatal cerebellum may be particularly sensitive to
injury in PITP/ mice because it attempts to sustain the
extraordinary rates of cell proliferation that accompany the
postnatal development of this organ in the face of a challenging
energetic environment. Similarly, Purkinje cells and motor
neurons are very large and metabolically active cells that are
sensitive to a variety of insults. We suggest PITP/ Purkinje
cell and motor neuron defects also represent manifestations of
energy deficit in these cells, thereby raising the possibility that
a significant component of the spinocerebellar disorder arises
from the intrinsic hypoglycemia and/or the intestinal and he-
patic steatosis of PITP/ mice.
Cellular Mechanisms for PITP Function in the Mouse?—
The lines of evidence linking PITP to potentiation of PIP
FIG. 10. Pancreatic islet cells and the unfolded protein response in PITP/ mice. A, number of pancreatic islets in whole pancreas from
PITP/ and PITP/ mice. Whole pancreata were recovered from each of two PITP/ and PITP/ mice. The individual PITP/
pancreata were serially sectioned into 48 and 60 consecutive sections, respectively, whereas both PITP/ pancreata were each sectioned into 48
serial sections. Islets were then comprehensively counted for every section of each individual pancreas so that the total number of islets per organ
was determined. The data represent the averages of the two reconstructions for PITP/ and PITP/ pancreas (solid and open bars,
respectively). B, histology of endocrine pancreas. Images from hematoxylin/eosin-stained sections of PITP/ and PITP/ pancreas. Bars are
50 m. C, viability of PITP/ (solid bars) and PITP/ (hatched bars) ES cells and MEFs as a function of period of glucose starvation is
indicated. Living cells were identified by a trypan blue exclusion assay. D, ER stress-induced inhibition of protein synthesis. MEFs of appropriate
genotype (PITP/, solid bars; PITP/, hatched bars) were incubated in the presence or absence of 10 mM dithiothreitol (DTT; 15 min) or 1 M
thapsigargin (Tg; 30 min) prior to and during a 20-min pulse-radiolabeling with [35S]methionine (100 Ci/ml). Relative incorporation of radiolabel
into protein was quantified as trichloroacetic acid-precipitable radioactivity and is presented as an average percentage of that measured for
mock-treated control cells (100%). Values are derived from triplicate determinations from three independent experiments. PITP/ and
PITP/ MEFs exhibit essentially indistinguishable rates of incorporation of [35S]methionine into protein. E, CHOP and calnexin expression.
Cell-free extracts were prepared from PITP/ and PITP/ MEFs after an 18-h incubation with 0, 10, 20, and 50 g/ml tunicamycin (at
bottom). Equivalent amounts of protein were loaded for each sample (20 g) and resolved by SDS-PAGE. Proteins were transferred to nitrocel-
lulose, and the resulting blot was probed with anti-CHOP and anti-calnexin antibodies (Santa Cruz Biotechnology) and developed by enhanced
chemiluminescence.
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synthesis suggest that the tissue defects of PITP/ mice
result from deranged PIP metabolism. A demonstration that
this is indeed the case remains elusive as such derangements
are not apparent in bulk PtdIns, PtdIns-3-phosphate, PtdIns-
4-phosphate, or PtdIns-4,5-bisphosphate levels in PITP/
ES cells (17) or MEFs (this study, not shown). Our data indi-
cate that PITP does not play a critical role in regulating
dynamics of cell-essential phospholipid pools in most cell types.
With regard to dysregulation of cellular homeostasis in
PITP nullizygous mice, we find that derangement of ER func-
tion is a common theme. PITPs are classically invoked to func-
tion as lipid carriers that ferry PtdIns from its ER site of
synthesis to signaling membranes (plasma membrane and
Golgi) so that dynamic PIP pools can be replenished. In its
simplest form, this model predicts that PITP deficiency will
compromise signaling in membranes distinct from the ER.
Although it remains possible that disruptions of PITP-medi-
ated signaling in non-ER compartments manifest themselves
indirectly in an ER pathology, the consistent smooth ER ab-
normalities of PITP/ spinal and cerebellar neurons, entero-
cytes, and hepatocytes suggest that the ER may itself represent
a primary target of PITP function. In this regard, PITP-de-
pendent egress of PtdIns from the cytoplasmic leaflet of ER
membranes may be required for ER function via unanticipated
mechanisms. Alternatively, PITP may play unforeseen ER
signaling functions that do not require PITP-mediated trans-
fer of lipid between organelles.
With regard to ER functions for PITP, we entertained the
idea that coupling of induction of UPR to ER secretory load is
PITP-dependent and is compromised in PITP/ cells. Al-
though our finding that PITP/ ES cells and MEFs are
UPR-competent argues against this idea, we cannot exclude
the possibility that UPR defects in PITP/ mice are mani-
fested only in professional secretory tissues (e.g. pancreatic
islet cells, Purkinje cells, enterocytes, and hepatocytes) where
high levels of cargo processing in the ER must occur efficiently.
An alternative possibility is that PITP plays a direct and
specific role in membrane trafficking from the ER in profes-
sional secretory cells by playing a direct role in facilitating
membrane trafficking at the level of budding of specific ER-
derived transport vesicles. This proposed activity is congru-
ent with the role of PITPs in yeast membrane trafficking (1,
3–5). The accumulation of dietary neutral lipids in the lumen
of the enterocyte and hepatocyte ER is consistent with such a
function. Although constitutive and regulated secretory path-
way function is normal in PITP/ ES cells (17), and devel-
opment of PITP/ mice to term is also inconsistent with
wholesale defects in membrane trafficking from the ER of
nullizygous cells, we propose that the ER membrane traffick-
ing function of PITP exhibits a large degree of cargo
specificity.
Is there independent supporting evidence for such a pro-
posal? It was recently demonstrated that inactivation of the
SARA2 isoform of the Sar1p GTPase forms a genetic basis for
human CRD (40). Sar1p is required for the budding of COPII
vesicles from ER membranes and for the concentration of cargo
into such transport vesicles (41). Our data, when coupled with
the demonstrations of a role for Sar1p in human CRD, suggest
the attractive hypothesis that PITP regulates the Sar1p
GTPase cycle in ER membranes. We propose that a dedicated
PITP/Sar1p interface is required to optimize assembly and
packaging of unusual luminal cargoes (such as large TG cores)
into ER-derived transport vesicles. This model shares common
features with previous proposals positing that the Sec14p
PITP regulates the activity of specific ADP-ribosylation factor
GTPase-activating proteins required for biogenesis of secretory
cargo-laden transport vesicles from trans-Golgi membranes in
yeast (6, 42).
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